The Ozempic Effect: Weight Loss, Health Benefits, and the High Price of Inaction A recent study presented at the European Congress on Obesity (ECO 2026) examined the significant health benefits associated with substantial weight loss in patients taking GLP 1 medications such as Ozempic.
The findings underscore the importance of sustained weight loss in mitigating the risks linked to obesity related diseases.
The study analyzed data from nearly 90,000 patients in the United States and found that those who achieved significant weight loss – a reduction in body mass index (BMI) by at least 15% – experienced lower risks for conditions like osteoarthritis, chronic kidney disease, obstructive sleep apnea, and heart failure.